Temozolomide 100 Mg Capsule Suppliers & Bulk Manufacturers
Available Forms: Capsule and Powder for reconstitution
Available Strengths: Capsule( 5 mg, 20 mg, 100 mg, 140 mg, 180 mg, 250 mg); Powder( 100 mg/vial)
Reference Brands: Temodar(US), Temodal (EU)
Category:
Oncology Cancer Care
emozolomide (Temodar/Temodal) is an oral chemotherapy drug used to treat glioblastoma and anaplastic astrocytoma. Approved in the US and EU, it’s available in 5–250 mg capsules and 100 mg IV form. Trusted by oncology specialists, it offers high bioavailability and compliance. Ideal for B2B pharma sourcing, licensing, or bulk supply.
Temozolomide 100 mg Capsule is available in Capsule and Powder for reconstitution
and strengths such as Capsule( 5 mg, 20 mg, 100 mg, 140 mg, 180 mg, 250 mg); Powder( 100 mg/vial).
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Temozolomide 100 mg Capsule is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Temozolomide 100 mg Capsule can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Temozolomide (Temodar/Temodal) is a potent oral alkylating chemotherapy agent used in the treatment of glioblastoma multiforme and anaplastic astrocytoma. Approved by the FDA (as Temodar) and EMA (as Temodal), it is available in capsule strengths of 5 mg to 250 mg and as a 100 mg injectable vial for IV use. Widely used in neuro-oncology protocols, Temozolomide offers excellent bioavailability and treatment compliance. Multiple generic versions are available from trusted global manufacturers. Ideal for pharmaceutical B2B partners in the US and EU seeking reliable oncology portfolio expansion. Contact us for bulk API supply, licensing, or third-party manufacturing.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing